We audited the marketing at Arine
AI medication optimization platform for health plans and providers
This page was built using the same AI infrastructure we deploy for clients.
Month-to-month. Cancel anytime.
No visible paid search presence despite competing in high-intent B2B2C healthcare market where decision-makers actively research medication management solutions
Limited AEO positioning means missing AI assistant queries about medication safety, adherence optimization, and cost-effective therapeutic alternatives
Minimal founder/executive visibility in healthcare AI and payer innovation conversations where Plevinson's marketing expertise and Dvries' clinical credibility could establish market authority
AI-Forward Companies Trust MarketerHire
Plaid
MasterClass
Constant Contact
Netflix
Noom
TinuitiArine's Leadership
We mapped your current team to understand where MH-1 fits in.
MH-1 doesn't replace your team. It becomes your marketing team: dedicated humans + AI agents running execution at scale while you focus on product.
Here's Where You Stand
Series C healthcare AI company with funding and scale, but underdeveloped demand generation relative to competitive payer technology landscape
Likely basic organic presence for medication optimization terms, but unclear if capturing health plan procurement and risk-based provider searches
MH-1: SEO agent maps high-intent payer and provider keywords, builds clinical authority content around medication therapy management outcomes
Minimal positioning for AI assistant queries about medication safety, drug interaction prevention, and member adherence analytics
MH-1: AEO agent creates structured data and snippets for medication optimization use cases, targets Claude and ChatGPT clinical decision-support queries
No visible paid strategy targeting health plan executives, pharmacy directors, and risk-based provider CFOs evaluating medication cost and safety platforms
MH-1: Paid agent runs LinkedIn and search campaigns targeting payer technology buyers, emphasizes member outcome improvements and cost reduction metrics
Some clinical credibility exists, but limited public content addressing payer pain points around medication waste, non-adherence, and drug-drug interactions
MH-1: Content agent develops case studies and research showcasing medication optimization impact on member outcomes, compliance, and plan profitability
Health plan customers likely undermonetized post-contract. No visible expansion motion toward secondary use cases like specialty pharmacy optimization or member-facing adherence
MH-1: Lifecycle agent identifies expansion triggers within existing accounts, nurtures secondary buyers in pharmacy and clinical teams with targeted expansion campaigns
Top Growth Opportunities
Health plan CIOs and pharmacy directors actively evaluate medication management platforms. No visible paid or outbound strategy capturing this high-intent segment during RFP and selection cycles
MH-1 runs LinkedIn and Google Search campaigns targeting payer procurement keywords, coordinates with outbound agent to reach pharmacy and clinical leadership
Healthcare professionals query LLMs about drug interactions, therapy optimization, and medication safety. Arine's clinical AI has no presence in these conversations
AEO agent optimizes clinical decision support content for AI assistants, generates structured data for medication safety and therapy recommendation scenarios
Plevinson's marketing and YC background, plus Dvries' clinical co-founder story, are underlevered in industry conversations about AI-driven medication management and cost reduction
LinkedIn agent amplifies founder/exec voices in healthcare AI, payer innovation, and medication safety communities. Newsletter agent builds subscriber base of payer decision-makers
3 Humans + 7 AI Agents
A dedicated marketing team built specifically for Arine. The humans handle strategy and judgment. The AI agents handle execution at scale.
Human Experts
Owns Arine's growth roadmap. Pipeline strategy, account expansion playbooks, board-ready reporting. Translates AI insights into revenue.
Runs paid acquisition across LinkedIn and Google. Manages creative testing, budget allocation, and pipeline attribution.
Builds thought leadership on LinkedIn. Creates long-form content targeting your ICP. Manages the content-to-pipeline engine.
AI Agents
Monitors AI citation visibility across 6 LLMs weekly. Builds content targeting category queries to increase Arine's presence in AI-generated answers.
Produces LinkedIn ad variants targeting your ICP. Tests headlines, visuals, and offers at 10x the speed of manual production.
Builds lifecycle sequences: onboarding, expansion triggers, champion nurture, and re-engagement for dormant accounts.
Founder thought leadership. Builds the narrative that drives enterprise inbound from senior decision-makers.
Tracks competitors. Monitors positioning changes, ad spend, content strategy. Informs your counter-positioning.
Attribution by channel, pipeline velocity, budget waste detection. Weekly synthesis reports with AI-generated recommendations.
Weekly market intelligence digest curated from Arine's industry signals. Positions you as the intelligence layer. Drives inbound pipeline from subscribers.
Active Workflows
Here's what the MH-1 system would be doing for Arine from week 1.
AEO agent monitors LLM queries about medication optimization, drug safety, therapy recommendations, and payer cost-reduction strategies. Builds clinical content and structured data to surface Arine in AI assistant responses.
LinkedIn agent amplifies Plevinson's marketing insights on healthcare AI adoption and Dvries' clinical expertise in medication management. Coordinates founder voice with topical payer innovation conversations.
Paid agent segments campaigns by buyer persona: health plan executives (ROI/cost), pharmacy directors (safety/compliance), risk-based providers (margin). Targets LinkedIn, Google Search, and healthcare industry publications.
Lifecycle agent identifies post-contract expansion triggers within health plan accounts. Nurtures pharmacy, clinical, and secondary care teams with targeted content on specialty medication optimization and member adherence programs.
Competitive watch agent tracks Argon-AI, HealthMyne, and other medication AI vendors. Identifies content gaps where Arine's clinical depth and payer outcomes can establish differentiation.
Pipeline intelligence agent scores health plan and provider accounts by medication optimization spending, payer size, and specialty pharmacy volume. Coordinates with outbound for high-intent account selection.
Traditional Marketing vs. MH-1
Traditional Approach
MH-1 System
Audit. Sprint. Optimize.
3 phases. Real output every 2 weeks. You see results, not decks.
AI Audit + Growth Roadmap
Full diagnostic of Arine's marketing infrastructure: SEO, AEO visibility, paid, content, lifecycle. Prioritized roadmap tied to pipeline metrics. Delivered in 7 days.
Sprint-Based Execution
2-week sprint cycles. Real campaigns, not presentations. Each sprint ships measurable output across your priority channels.
Compounding Intelligence
AI agents monitor your channels 24/7. They catch budget waste, detect creative fatigue, track AI citation changes, and run A/B experiments autonomously. Week 12 is measurably better than week 1.
AI Marketing Operating System
3 elite humans + AI agents operating your growth system
Output multiplier: ~10x output at a fraction of the cost. The system gets smarter every week.
Month-to-month. Cancel anytime.
Common Questions
How does MH-1 differ from a marketing agency?
MH-1 pairs 3 elite human marketers with 7 AI agents. The humans handle strategy, creative direction, and judgment calls. The AI agents handle execution at scale: generating ad variants, monitoring competitors, building email sequences, tracking citations across LLMs, running A/B experiments autonomously. You get the quality of a senior marketing team with the output volume of a 15-person department.
What kind of results can we expect in the first 90 days?
First 90 days establish baseline audit across payer procurement keywords, AEO visibility for clinical and safety queries, and competitive content gaps. Paid campaigns launch targeting health plan CFOs and pharmacy leaders. Lifecycle agent maps existing customer expansion personas. LinkedIn agent activates founder voices. By week 12, we measure lift in payer pipeline activity and AEO impressions for medication optimization terms.
How does AEO help Arine reach healthcare professionals asking about medication optimization.
Healthcare professionals, pharmacists, and payer clinicians query AI assistants about drug interactions, therapy alternatives, and medication adherence solutions. AEO positions Arine's clinical data and optimization algorithms to surface in these conversations, capturing high-intent decision-makers researching medication management platforms before they issue RFPs.
Can we cancel anytime?
Yes. MH-1 is month-to-month with no long-term contracts. We earn your business every sprint. That said, compounding effects kick in around month 3 as the AI agents accumulate data and the system learns what works for Arine specifically.
How is this page personalized for Arine?
This page was researched, audited, and generated using the same AI infrastructure we deploy for clients. The channel scores, team mapping, growth opportunities, and recommended agents are all based on real analysis of Arine's current marketing. This is a live demo of MH-1's capabilities.
Run your medication optimization growth like clinical AI optimizes member care
The system gets smarter every cycle. Let's talk about building it for Arine.
Book a Strategy CallMonth-to-month. Cancel anytime.